RK
Rick Klausner
Angel InvestorQuietRick Klausner is a Chief Executive Officer at Lyell Immunopharma.
San Francisco Bay Area, United StatesFounded 2014
4
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Rick Klausner.
Investment Thesis & Strategy
As an angel investor, Rick Klausner likely invests in various stages and industries, seeking innovative companies with high growth potential.
Investment Activity
Deals per year over the last 2 years
2
20172
2018Portfolio Companies
Selected investments from their portfolio of 4 companies
L
LifeMine Therapeutics
Biotech · Series A, 2018
M
Meatable
Food & Beverage · Seed, 2018
b
bit.bio
Biotech · Series A, 2017
W
Wisdo
Healthcare · Seed, 2017
Frequently Asked Questions
Rick Klausner focuses on Pre-seed, Seed stage investments.
Related Investors
Scott Stanford
San Francisco Bay Area, United States · 89 deals
Sarah Smith
San Francisco Bay Area, United States · 82 deals
Eric Ver Ploeg
San Francisco Bay Area, United States · 72 deals
Ethan Batraski
San Francisco Bay Area, United States · 71 deals
Varun Gupta
San Francisco Bay Area, United States · 62 deals
Rashmi Gopinath
San Francisco Bay Area, United States · 53 deals